These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11386045)

  • 1. [Impact of the exclusion of donors who have stayed in the United Kingdom on the residual risk of HIV transmission by blood transfusion].
    Pillonel J; Couroucé AM; Saura C; Désenclos JC
    Transfus Clin Biol; 2001 Apr; 8(2):85-93. PubMed ID: 11386045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies.
    Correll PK; Law MG; Seed CR; Gust A; Buring M; Dax EM; Keller AJ; Kaldor JM
    Vox Sang; 2001 Jul; 81(1):6-11. PubMed ID: 11520409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first-time and repeat blood donations in Zimbabwe: implications on blood safety.
    Mapako T; Mvere DA; Chitiyo ME; Rusakaniko S; Postma MJ; van Hulst M
    Transfusion; 2013 Oct; 53(10 Pt 2):2413-21. PubMed ID: 23789991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil.
    Sabino EC; Gonçalez TT; Carneiro-Proietti AB; Sarr M; Ferreira JE; Sampaio DA; Salles NA; Wright DJ; Custer B; Busch M;
    Transfusion; 2012 Apr; 52(4):870-9. PubMed ID: 21981109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003.
    Soldan K; Davison K; Dow B
    Euro Surveill; 2005 Feb; 10(2):17-9. PubMed ID: 15735312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections.
    Pillonel J; Barin F; Laperche S; Bernillon P; Le Vu S; Brunet S; Thierry D; Desenclos JC;
    Transfusion; 2008 Aug; 48(8):1567-75. PubMed ID: 18482193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C; Araújo F
    Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence and incidence of HIV and hepatitis B among blood donors and estimated residual risk of transmission of HIV and HBV virus by blood transfusion. A study at the Provincial General Referee Hospital Bukavu, Democratic Republic of the Congo].
    Namululi BA; Guerrieri C; Dramaix MW
    Rev Epidemiol Sante Publique; 2013 Apr; 61(2):139-44. PubMed ID: 23498094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
    Pillonel J; Laperche S; ; ;
    Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
    Weusten JJ; van Drimmelen HA; Lelie PN
    Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study.
    Busch MP; Glynn SA; Schreiber GB
    Transfusion; 1997 Oct; 37(10):996-1002. PubMed ID: 9354816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of HIV transfusion transmission risk in South Africa: a 10-year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes.
    Vermeulen M; Lelie N; Coleman C; Sykes W; Jacobs G; Swanevelder R; Busch M; van Zyl G; Grebe E; Welte A; Reddy R
    Transfusion; 2019 Jan; 59(1):267-276. PubMed ID: 30265757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Fearon MA; Allain JP
    Vox Sang; 2012 Jul; 103(1):83-6. PubMed ID: 22289147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil.
    Barreto CC; Sabino EC; Gonçalez TT; Laycock ME; Pappalardo BL; Salles NA; Wright DJ; Chamone DF; Busch MP
    Transfusion; 2005 Nov; 45(11):1709-14. PubMed ID: 16271094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men.
    Grebe E; Busch MP; Notari EP; Bruhn R; Quiner C; Hindes D; Stone M; Bakkour S; Yang H; Williamson P; Kessler D; Reik R; Stramer SL; Glynn SA; Anderson SA; Williams AE; Custer B
    Blood; 2020 Sep; 136(11):1359-1367. PubMed ID: 32693408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.